All lobbying filings
SPLITOAK STRATEGIES LLC
SPLITOAK STRATEGIES LLC filed a Q3 report for CARIS LIFE SCIENCES, INC. on October 20, 2026, reporting $40,000 in lobbying income.
Lobbying for CARIS LIFE SCIENCES, INC. · Providing precision medicine services to patients battling aggressive cancers.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Texas
Lobbyists on this filing
2
-
AMY JENSENPreviously held: Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst
-
SARAH KUEHL EGGE New on this filingPreviously held: 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee for Deficit Reduction
Government bodies contacted
2
Lobbying activity
2
Role of molecular profiling in cancer care; access to molecular profiling technologies in Medicare; prior authorization reform in Medicare; Date of Service Rule Reform for lab services; and appropriate reimbursement for cutting edge cancer diagnostic testing including PAMA reporting.
Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; S 2355, Patients Deserve Price Tags